- Home
- PL vs AMPH Comparison
PL vs AMPH Comparison
Compare PL & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PL
- AMPH
- Stock Information
- Founded
- PL 2010
- AMPH 1996
- Country
- PL United States
- AMPH United States
- Employees
- PL N/A
- AMPH N/A
- Industry
- PL Aerospace
- AMPH Biotechnology: Pharmaceutical Preparations
- Sector
- PL Industrials
- AMPH Health Care
- Exchange
- PL Nasdaq
- AMPH Nasdaq
- Market Cap
- PL 947.7M
- AMPH 1.1B
- IPO Year
- PL N/A
- AMPH 2014
- Fundamental
- Price
- PL $3.80
- AMPH $25.38
- Analyst Decision
- PL Buy
- AMPH Hold
- Analyst Count
- PL 11
- AMPH 5
- Target Price
- PL $5.53
- AMPH $38.00
- AVG Volume (30 Days)
- PL 3.4M
- AMPH 553.5K
- Earning Date
- PL 06-04-2025
- AMPH 05-07-2025
- Dividend Yield
- PL N/A
- AMPH N/A
- EPS Growth
- PL N/A
- AMPH N/A
- EPS
- PL N/A
- AMPH 2.77
- Revenue
- PL $244,352,000.00
- AMPH $730,659,000.00
- Revenue This Year
- PL $14.08
- AMPH $0.65
- Revenue Next Year
- PL $21.49
- AMPH $5.26
- P/E Ratio
- PL N/A
- AMPH $9.20
- Revenue Growth
- PL 10.72
- AMPH 8.05
- 52 Week Low
- PL $1.73
- AMPH $22.64
- 52 Week High
- PL $6.71
- AMPH $53.96
- Technical
- Relative Strength Index (RSI)
- PL 53.14
- AMPH 53.98
- Support Level
- PL $3.47
- AMPH $25.15
- Resistance Level
- PL $4.12
- AMPH $25.72
- Average True Range (ATR)
- PL 0.18
- AMPH 0.72
- MACD
- PL 0.01
- AMPH 0.21
- Stochastic Oscillator
- PL 50.08
- AMPH 76.49
About PL Planet Labs PBC
Planet Labs PBC is an Earth-imaging company. The company provides daily satellite data that helps businesses, governments, researchers, and journalists understand the physical world and take action.
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.